nach oben

Journal of Neuro-Oncology

Erschienen in:

01.12.2015 | Topic Review & Clinical Guidelines

The role of biopsy in the management of patients with presumed diffuse low grade glioma

A systematic review and evidence-based clinical practice guideline

verfasst von: Brian T. Ragel, Timothy C. Ryken, Steven N. Kalkanis, Mateo Ziu, Daniel Cahill, Jeffrey J. Olson

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Question

What is the optimal role of biopsy in the initial management of presumptive low-grade glioma in adults?

Target population

Adult patients with imaging suggestive of a low-grade glioma.

Recommendations

Level III

Stereotactic biopsy is recommended when definitive surgical resection is limited by lesions that are deep-seated, not resectable, and/or located within eloquent cortex, or in patients unable to undergo craniotomy due to medical co-morbidities to obtain the critical tissue diagnosis needed for targeted treatment planning for patients with low-grade gliomas.

Question

What is the best technique for brain biopsy?

Target population

Adult patients with imaging suggestive of a low-grade glioma.

Recommendations

Level III

Frameless and frame-based stereotactic brain biopsy for low-grade gliomas are recommended based on clinical circumstances as they provide similar diagnostic yield, diagnostic accuracy, morbidity, and mortality. It is recommended the surgeon consider advanced imaging techniques (e.g., perfusion, spectroscopy, metabolic studies) to target specific regions of interest to potentially improve diagnostic accuracy.

Jansen NL, Graute V, Armbruster L et al (2012) MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Eur J Nucl Med Mol Imaging 39(6):1021–1029CrossRefPubMed

Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79(4):533–536CrossRefPubMed

Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 3(3):193–200PubMedCentralPubMed

Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL (2010) Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol 96(1):11–16PubMedCentralCrossRefPubMed

Feiden W, Steude U, Bise K, Gundisch O (1991) Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14(1):51–56PubMed

Ranjan A, Rajshekhar V, Joseph T, Chandy MJ, Chandi SM (1993) Nondiagnostic CT-guided stereotactic biopsies in a series of 407 cases: influence of CT morphology and operator experience. J Neurosurg 79(6):839–844CrossRefPubMed

Voges J, Schroder R, Treuer H et al (1993) CT-guided and computer assisted stereotactic biopsy. technique, results, indications. Acta Neurochir (Wien) 125(1–4):142–149CrossRef

Arbit E, Galicich JH (1994) Importance of image-guided stereotactic biopsy to confirm diagnosis in an oncological setting. Ann Surg Oncol 1(5):368–372CrossRefPubMed

Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81(2):165–168CrossRefPubMed

10.

Grunert P, Ungersbock K, Bohl J, Kitz K, Hopf N (1994) Results of 200 intracranial stereotactic biopsies. Neurosurg Rev 17(1):59–66CrossRefPubMed

11.

Levivier M, Goldman S, Pirotte B et al (1995) Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 82(3):445–452CrossRefPubMed

12.

Pirotte B, Goldman S, Bidaut LM et al (1995) Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir (Wien) 134(1–2):79–82CrossRef

13.

Goldman S, Levivier M, Pirotte B et al (1996) Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78(5):1098–1106CrossRefPubMed

14.

Krieger MD, Chandrasoma PT, Zee CS, Apuzzo ML (1998) Role of stereotactic biopsy in the diagnosis and management of brain tumors. Semin Surg Oncol 14(1):13–25CrossRefPubMed

15.

Kulkarni AV, Guha A, Lozano A, Bernstein M (1998) Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89(1):31–35CrossRefPubMed

16.

Sawin PD, Hitchon PW, Follett KA, Torner JC (1998) Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 49(6):640–649CrossRefPubMed

17.

Barnett GH, Miller DW, Weisenberger J (1999) Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases. J Neurosurg 91(4):569–576CrossRefPubMed

18.

Kondziolka D, Lunsford LD (1999) The role of stereotactic biopsy in the management of gliomas. J Neurooncol 42(3):205–213CrossRefPubMed

19.

Fontaine D, Dormont D, Hasboun D et al (2000) Magnetic resonance-guided stereotactic biopsies: results in 100 consecutive cases. Acta Neurochir 142(3):249–255; discussion 255–256CrossRefPubMed

20.

Massager N, David P, Goldman S et al (2000) Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 93(6):951–957CrossRefPubMed

21.

Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford LD (2001) Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94(4):545–551CrossRefPubMed

22.

Kaakaji W, Barnett GH, Bernhard D, Warbel A, Valaitis K, Stamp S (2001) Clinical and economic consequences of early discharge of patients following supratentorial stereotactic brain biopsy. J Neurosurg 94(6):892–898CrossRefPubMed

23.

Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ (2001) The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir 143(6):539–545; discussion 545–546CrossRefPubMed

24.

Paleologos TS, Dorward NL, Wadley JP, Thomas DG (2001) Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases. Neurosurgery 49(4):830–835; discussion 835–837PubMed

25.

Ulm AJ, Bova FJ, Friedman WA (2001) Stereotactic biopsy aided by a computer graphics workstation: experience with 200 consecutive cases. Surg Neurol 56(6):366–371; discussion 371–372CrossRefPubMed

26.

Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y (2002) Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 97(2):354–362CrossRefPubMed

27.

Bhardwaj RD, Bernstein M (2002) Prospective feasibility study of outpatient stereotactic brain lesion biopsy. Neurosurgery 51(2):358–361; discussion 361–364PubMed

28.

Dorward NL, Paleologos TS, Alberti O, Thomas DG (2002) The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 16(2):110–118CrossRefPubMed

29.

Kim JE, Kim DG, Paek SH, Jung HW (2003) Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir 145(7):547–554; discussion 554–555CrossRefPubMed

30.

Seliem RM, Assaad MW, Gorombey SJ, Moral LA, Kirkwood JR, Otis CN (2003) Fine-needle aspiration biopsy of the central nervous system performed freehand under computed tomography guidance without stereotactic instrumentation. Cancer 99(5):277–284CrossRefPubMed

31.

Pirotte B, Goldman S, Massager N et al (2004) Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45(8):1293–1298PubMed

32.

Aker FV, Hakan T, Karadereler S, Erkan M (2005) Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology 25(3):207–213CrossRefPubMed

33.

Grossman R, Sadetzki S, Spiegelmann R, Ram Z (2005) Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir 147(6):627–631; discussion 631CrossRefPubMed

34.

Hemm S, Rigau V, Chevalier J et al (2005) Stereotactic coregistration of 201Tl SPECT and MRI applied to brain tumor biopsies. J Nucl Med 46(7):1151–1157PubMed

35.

Heper AO, Erden E, Savas A et al (2005) An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 64(Suppl 2):S82–S88CrossRefPubMed

36.

Hertel F, Feiden W, Bettag M (2005) The value of micro-Doppler in stereotactic brain biopsy. Minim Invasive Neurosurg 48(3):165–168CrossRefPubMed

37.

Maia AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol 26(4):777–783PubMed

38.

McGirt MJ, Woodworth GF, Coon AL et al (2005) Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102(5):897–901CrossRefPubMed

39.

Smith JS, Quinones-Hinojosa A, Barbaro NM, McDermott MW (2005) Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neurooncol 73(2):173–179CrossRefPubMed

40.

Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD (2006) Stereotactic biopsy of brain stem masses: decision analysis and literature review. Surg Neurol 66(5):484–490CrossRefPubMed

41.

Woodworth GF, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD (2006) Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 104(2):233–237CrossRefPubMed

42.

Popperl G, Kreth FW, Mehrkens JH et al (2007) FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 34(12):1933–1942CrossRefPubMed

43.

Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ (2008) Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 150(1):23–29CrossRef

44.

Kongkham PN, Knifed E, Tamber MS, Bernstein M (2008) Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci 35(1):79–84CrossRefPubMed

45.

Lunsford LD, Niranjan A, Khan AA, Kondziolka D (2008) Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact Funct Neurosurg 86(5):278–287CrossRefPubMed

46.

Stockhammer F, Plotkin M, Amthauer H, van Landeghem FK, Woiciechowsky C (2008) Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neurooncol 88(2):205–210CrossRefPubMed

47.

Air EL, Leach JL, Warnick RE, McPherson CM (2009) Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases. J Neurosurg 111(4):820–824CrossRefPubMed

48.

Rachinger W, Grau S, Holtmannspotter M, Herms J, Tonn JC, Kreth FW (2009) Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry 80(10):1134–1139CrossRefPubMed

49.

Dammers R, Schouten JW, Haitsma IK, Vincent AJ, Kros JM, Dirven CM (2010) Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Acta Neurochir (Wien) 152(11):1915–1921CrossRef

50.

Meyer M, Keith-Rokosh J, Reddy H, Megyesi J, Hammond RR (2010) Sources of error in neuropathology intraoperative diagnosis. Can J Neurol Sci 37(5):620–624CrossRefPubMed

51.

Shooman D, Belli A, Grundy PL (2010) Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg 113(2):170–178CrossRefPubMed

52.

Weber MA, Henze M, Tuttenberg J et al (2010) Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Invest Radiol 45(12):755–768CrossRefPubMed

53.

Amin DV, Lozanne K, Parry PV, Engh JA, Seelman K, Mintz A (2011) Image-guided frameless stereotactic needle biopsy in awake patients without the use of rigid head fixation. J Neurosurg 114(5):1414–1420PubMed

54.

Ersahin M, Karaaslan N, Gurbuz MS et al (2011) The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique. Turkish Neurosurg 21(4):582–590

55.

Kunz M, Thon N, Eigenbrod S et al (2011) Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol. 13(3):307–316PubMedCentralCrossRefPubMed

56.

Quinn J, Spiro D, Schulder M (2011) Stereotactic brain biopsy with a low-field intraoperative magnetic resonance imager. Neurosurgery 68(1 Suppl Operative):217–224; discussion 224PubMed

57.

Bekelis K, Radwan TA, Desai A, Roberts DW (2012) Frameless robotically targeted stereotactic brain biopsy: feasibility, diagnostic yield, and safety. J Neurosurg 116(5):1002–1006CrossRefPubMed

58.

Christoforidis GA, Ming Yang M, Amir Abduljalil P et al (2012) “Tumoral Pseudoblush” identified within gliomas at high-spatial-resolution ultrahigh-field-strength gradient-echo MR imaging corresponds to microvascularity at stereotactic biopsy. Radiology 264(1):8CrossRef

59.

Dellaretti M, Reyns N, Touzet G et al (2012) Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90(2):79–83CrossRefPubMed

60.

Dellaretti M, Touzet G, Reyns N et al (2012) Correlation between magnetic resonance imaging findings and histological diagnosis of intrinsic brainstem lesions in adults. Neuro Oncol. 14(3):381–385PubMedCentralCrossRefPubMed

61.

Gempt J, Buchmann N, Ryang YM et al (2012) Frameless image-guided stereotaxy with real-time visual feedback for brain biopsy. Acta Neurochir (Wien) 154(9):1663–1667CrossRef

62.

Lefranc M, Monet P, Desenclos C et al (2012) Perfusion MRI as a neurosurgical tool for improved targeting in stereotactic tumor biopsies. Stereotact Funct Neurosurg 90(4):240–247CrossRefPubMed

63.

Frati A, Pichierri A, Bastianello S et al (2011) Frameless stereotactic cerebral biopsy: our experience in 296 cases. Stereotact Funct Neurosurg 89(4):234–245CrossRefPubMed

64.

Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD (2005) Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 27(4):358–362CrossRefPubMed

Titel: The role of biopsy in the management of patients with presumed diffuse low grade glioma
A systematic review and evidence-based clinical practice guideline
verfasst von: Brian T. Ragel
Timothy C. Ryken
Steven N. Kalkanis
Mateo Ziu
Daniel Cahill
Jeffrey J. Olson
Publikationsdatum: 01.12.2015
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2015
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-1866-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Question

Target population

Recommendations

Level III

Question

Target population

Recommendations

Level III

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Low grade glioma guidelines: Foreword

The role of imaging in the management of adults with diffuse low grade glioma

Evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: introduction and methods

The role of neuropathology in the management of patients with diffuse low grade glioma

The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma

The role of radiotherapy in the management of patients with diffuse low grade glioma

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Update Neurologie